help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 30, 2007, doi:10.1164/rccm.200603-316OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200603-316OCv1
176/1/49    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoshino, T.
Right arrow Articles by Aizawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoshino, T.
Right arrow Articles by Aizawa, H.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 49-62, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200603-316OC


Original Article

Pulmonary Inflammation and Emphysema

Role of the Cytokines IL-18 and IL-13

Tomoaki Hoshino1,3, Seiya Kato2,6, Naoki Oka4, Haruki Imaoka1, Takashi Kinoshita1, Satoko Takei1, Yasuhiko Kitasato1, Tomotaka Kawayama1, Tsutomu Imaizumi4, Kentaro Yamada5, Howard A. Young3 and Hisamichi Aizawa1

1 Department of Internal Medicine 1, and 2 Pathology, Kurume University School of Medicine, Kurume, Japan; 3 Laboratory of Experimental Immunology, National Cancer Institute, Center for Cancer Research, Frederick, Maryland; 4 Internal Medicine 3, and Cardiovascular Research Institute, and 5 Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan; 6 Division of Pathology and Cell Biology, Graduate School and Faculty of Medicine, University of the Ryukyus, Okinawa, Japan

Correspondence and requests for reprints should be addressed to Tomoaki Hoshino, M.D., Ph.D., Department of Internal Medicine 1, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830–0011, Japan. E-mail: hoshino{at}med.kurume-u.ac.jp

Rationale: Chronic obstructive pulmonary disease (COPD) is believed to be an inflammatory cytokine–driven disease, but a causal basis that can be associated with a specific cytokine has not been directly demonstrated. We have previously reported that proinflammatory cytokine IL-18 expression is important in the pathogenesis of pulmonary inflammation and lung injury in mice. Our results demonstrate that IL-18 overproduction in the lungs can induce lung diseases, such as pulmonary inflammation, lung fibrosis, and COPD.

Objectives: We analyzed the role of IL-18 in the pathogenesis of COPD.

Methods: Using the human surfactant protein C promoter to drive expression of mature mouse IL-18 cDNA, we developed two different lines of transgenic (Tg) mice that overproduced mouse mature IL-18 in the lungs either constitutively or in response to doxycycline.

Measurements and Main Results: Constitutive overproduction of IL-18 in the lungs resulted in the increased production of IFN-{gamma}, IL-5, and IL-13, and chronic pulmonary lung inflammation with the appearance of CD8+ T cells, macrophages, neutrophils, and eosinophils. Increased lung volume, severe emphysematous change, dilatation of the right ventricle, and mild pulmonary hypertension were observed in (more than 15-wk-old) Tg mice. Interestingly, disruption of the IL-13 gene, but not the IFN-{gamma} gene, prevented emphysema and pulmonary inflammation in Tg mice. Moreover, when IL-18 production was induced in lung tissues for 4 weeks through the use of a doxycycline-dependent surfactant protein C promoter, interstitial inflammation was induced.

Conclusions: Our results indicate that IL-18 and IL-13 may have an important role in the pathogenesis of COPD.

Key Words: emphysema • IFN-{gamma} • IL-13 • IL-18 • transgenic mouse


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Overproduction of IL-18 in lungs induces emphysema in mice.

What This Study Adds to the Field
IL-18 may play an important role in the pathogenesis of chronic obstructive pulmonary disease.

 



This article has been cited by other articles:


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2007
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829.
[Full Text] [PDF]


Home page
Eur Respir JHome page
H. Imaoka, T. Hoshino, S. Takei, T. Kinoshita, M. Okamoto, T. Kawayama, S. Kato, H. Iwasaki, K. Watanabe, and H. Aizawa
Interleukin-18 production and pulmonary function in COPD
Eur. Respir. J., February 1, 2008; 31(2): 287 - 297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Bonay, A. Boutten, and B. Crestani
Cytokines in Pulmonary Emphysema: Can Results in Mice Be Translated to Humans?
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 238 - 238.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Hoshino, H. A. Young, and H. Aizawa
Cytokines in Pulmonary Emphysema: Can Results in Mice Be Translated to Humans?
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 238 - 239.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  ATS State of the Art 2009